The Lynx Group

Omid Hamid, MD


Authored Items

Case Studies in Immunotherapy

September 2014, Part 3 - Uncategorized

Despite recent advances, non–small-cell lung cancer (NSCLC) continues to be the leading cause of cancer-related deaths worldwide, and its cure remains elusive. New drugs targeting EGFR (epidermal growth factor receptor), EML4-ALK, ROS-1, and KRAS mutations have provided considerable benefit and new therapeutic options for patients. However, overall survival for patients [ Read More ]

Sign me up!